Document is current
Any future updates will be listed below
-
Authors
Sultana, Janet
Cutroneo, Paola Maria
Crisafulli, Salvatore
Puglisi, Gabriele
Caramori, Gaetano
Trifirò, Gianluca https://orcid.org/0000-0003-1147-7296
- License Information
-
More Information
Article History
First Online: 21 July 2020
Compliance with Ethical Standards
:
: No sources of funding were used to prepare this article.
: Gianluca Trifirò, has served on advisory boards for Sandoz, Hospira, Sanofi, Biogen, Ipsen and Shire; is the principal investigator of observational studies funded by several pharmaceutical companies (e.g. Amgen, AstraZeneca, Daiichi Sankyo and IBSA) to the University of Messina; and is scientific coordinator of the Master’s program ‘Pharmacovigilance, pharmacoepidemiology and pharmacoeconomics: real-world data evaluations’ at the University of Messina, which is partly funded by several pharmaceutical companies. Janet Sultana, Paola Maria Cutroneo, Salvatore Crisafulli, Gabriele Puglisi and Gaetano Caramori have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
: Software application or custom code: not applicable.
: All authors contributed equally to this work.
Free to read: This content has been made available to all.
